KRISTIN BRINK: Open Payments
NPI 1962423483 · MONROE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 33 payments from 15 companies in 2025. Trend: 2023 $243 · 2024 $529 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $143 |
| LivaNova USA, Inc. | 4 | $112 |
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Alkermes, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: REXULTI, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, COBENFY, INGREZZA, LYBALVI, FANAPT, VRAYLAR, Auvelity.
Industry payments across WI — which companies pay providers there.
